Aarti Pharmalabs Ltd

NSE: AARTIPHARM · BSE: 543748 · Pharmaceuticals & Biotechnology · 34 announcements

Share price: ₹975.00
Market cap: ₹8,841 Cr
Revenue (annual): ₹1,819 Cr
Net profit (annual): ₹174.7 Cr
P/E (TTM): 41.5×Sector 47.4×
Promoter holding: 42.86%-0.22% QoQ
FII holding: 8.17%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Promoter Selling 5 Management Change 4 Earnings Call 4 Other Announcement 3 Financial Results 3 Board Meeting Date 3 Share Pledge 2 Employee Stock Options 2 Dividend 2 Annual General Meeting 2 Production Started 1 Legal & Regulatory 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

7 Aug 2026 19:48 IST BSE

Financial ResultsAlfa Alert

Aarti Pharmalabs Q1 FY27 Results: Net Profit ₹76.1 Cr, Up 65.4% YoY

Aarti Pharmalabs Ltd reported revenue from operations of ₹535.8 Cr (+38.7% YoY) and net profit of ₹76.1 Cr (+65.4% YoY) for Q1 FY27.

Key figure: Net profit ₹76.1 Cr · +65.4% YoY

Open full results → Read the filing ↗

25 May 2026 21:04 IST NSE

Financial Results

Aarti Pharmalabs Q4 FY26 Results: Net Profit ₹61.1 Cr, Down 30.8% YoY

Aarti Pharmalabs Ltd reported revenue from operations of ₹582.6 Cr (+3.3% YoY) and net profit of ₹61.1 Cr (-30.8% YoY) for Q4 FY26.

Key figure: Net profit ₹61.1 Cr · -30.8% YoY

Open full results → Read the filing ↗

25 May 2026 21:03 IST NSE

Financial Results

Aarti Pharmalabs Financial Results

Aarti Pharmalabs reported its FY26 audited financial results and recommended a final dividend of Rs. 2 per share. The board also re-appointed cost and internal auditors.

Value: ₹2.00 Cr

Read the filing ↗